The Alpha-1 Research Program was established at the University of Florida College of Medicine in Gainesville, Florida in 1998 by the Alpha-1 Foundation.
The Program, under the direction of Mark L. Brantly, M.D., is devoted to the study of lung and liver disease associated with Alpha-1 Antitrypsin (AAT) Deficiency. Its resources and services are an important access point for the national and international medical and scientific communities.
Our mission is to improve the lives of alpha-antitrypsin individuals and their families through research and service by developing new therapies that target lung and liver disease associated with alpha-1 antitrypsin deficiency using a combination of basic and clinical research.
Services and Resources
The Alpha-1 Research Program resources and services include: